8 Min Read
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock indexes rose on Friday, with the S&P 500 on track for its best week in a year, as healthcare and consumer stocks rose. The Dow Jones industrial average was up 0.59 percent at 17,836.54, the S&P 500 was up 0.45 percent at 2,090.58 and the Nasdaq Composite was up 0.50 percent at 5,099.213.
** BIOMARIN PHARMACEUTICAL INC, $99.38, -3.62 pct
** SAREPTA THERAPEUTICS INC, $34.61, +32.76 pct
** PTC THERAPEUTICS INC, $27.9, -7.37 pct
U.S. Food and Drug Administration staff reviewers said clinical data to date did not merit approving the drug developer's muscle-wasting disorder drug.
Shares of Sarepta, which is developing rival product for DMD, rose. Shares of PTC, whose experimental DMD drug has also failed a late-stage study, fell.
** SPRINT CORP, $3.805, -6.05 pct
The company said it would raise about $1.1 billion in cash by selling and then leasing back some leased-out mobile devices to a company whose backers include SoftBank Group Corp. Sprint also cut its full-year adjusted EBITDA forecast to $6.8 billion-$7.1 billion from $7.2 billion-$7.6 billion, based on the deal and the inclusion of "transformation program costs."
** ABERCROMBIE & FITCH, $23.54, +20.78 pct
The teen apparel retailer said its quarterly profit more than doubled and same-store sales fell less than expected as company boosted gross margin by offering fewer promotions and controlling costs.
** NIKE INC, $131.21, +4.32 pct
The world's No. 1 sportswear maker said its board approved a new $12 billion share buyback program and a two-for-one split of its class A and class B shares.
** FOOT LOCKER INC, $64.65, +5.07 pct
The footwear retailer reported better-than-expected quarterly profit and sales, helped by strong demand for basketball and running shoes.
** GAP INC, $26.62, +6.10 pct
The apparel retailer's CEO Arthur Peck said on Thursday that Banana Republic and Gap brands would see a material improvement in spring.
Cowen and Co analysts said they were expecting product improvements, beginning in spring, to be driven by three categories that were outlined by the management - women's knits, dresses and denim.
** HORIZON PHARMA PLC, $20.21, +7.39 pct
** DEPOMED INC, $19.12, -1.39 pct
The Ireland-based drugmaker said it had withdrawn its offer to acquire Depomed following a court ruling that granted Depomed's motion for preliminary injunctive relief on Horizon's alleged used of confidential information.
** SUNEDISON INC, $2.59, -9.44 pct
JP Morgan cut its rating on the U.S. solar company's stock to "neutral" from "overweight". "We believe cash-drain associated with ongoing M&A, margin calls, earn-outs and litigation will require SunEdison to moderate growth relative to prior expectations," analysts wrote in a note.
** REVANCE THERAPEUTICS, $34.36, -5.76 pct
Seeking Alpha published a report by Richard Pearson, whose website Mox Reports says he focuses on due diligence issues in publicly traded equities. Pearson's report said Revance's data on a mid-stage study of its RT002 candidate against a placebo and Botox was misleading.
** PEABODY ENERGY CORP, $11.37, -3.97 pct
** CLOUD PEAK ENERGY INC, $2.88, -4.95 pct
** CONSOL ENERGY INC, $7.74, -1.15 pct
UBS cut its long-term sea-borne thermal coal price forecast by 33 percent and hard coking coal price forecast by 20 percent due to lack of growth in sea-borne demand and expectations of deflated capital and operating expenses.
** VIPSHOP HOLDINGS LTD, $15.74, +9.99 pct
Hedge fund Tiger Global Management LLC disclosed a 9.96 percent stake in the online discount retailer, according to a filing on Thursday.
** APTOSE BIOSCIENCES INC, $3.51, -33.90 pct
The drug developer said the U.S. Food and Drug Administration put its early-stage trial on a cancer drug on hold after a review found a malfunctioning infusion pump at a clinical site where the tests were being held.
** KALOBIOS PHARMACEUTICALS INC, $19.825, +90.63 pct
The drug developer said it appointed Martin Shkreli CEO after the controversial head of Turing Pharmaceuticals led a group of investors to buy 70 percent of its outstanding shares.
** MENTOR GRAPHICS CORP, $18.87, -32.07 pct
JP Morgan rated Mentor's stock "sell" after the electronic hardware and software design provider set its fourth-quarter and full-year revenue forecasts below Wall Street estimates.
** NIMBLE STORAGE INC, $10.06, -50.66 pct
The data storage maker reported bigger-than-expected quarterly loss as it shifts to flash-centric architectures from disk-centric architectures.
** HABIT RESTAURANTS INC, $23.125, +6.27 pct
The fast-casual burger chain operator postponed its previously announced secondary offering "in light of current capital market conditions".
** HIBBETT SPORTS INC, $33.75, +17.80 pct
The sporting goods retailer announced a new stock repurchase program of $300 million to replace the existing program, which expires in January. It also raised its earnings forecast for the year ending January to $2.87-$2.94 per share from $2.80-$2.90.
** UNIVERSAL INSURANCE HOLDINGS INC, $17.03, -12.93 pct
The property and casualty insurer's stock continued its fall since Lakewood Capital Management founder Anthony Bozza said this week he was shorting the stock. Universal Insurance met on Wednesday night to review Bozza's statements and authorized on Thursday a repurchase of up to $10 million shares through Dec. 31, 2016. (bit.ly/1MZ2VOC)
** BUILDERS FIRSTSOURCE INC, $13.155, -2.99 pct
The building products supplier said shareholder Warburg Pincus would offer 7 million shares. Builders FirstSource had 109.3 million shares outstanding as of Tuesday, according to Thomson Reuters data.
** PFIZER INC, $32.45, +0.50 pct
** ALLERGAN PLC, $311.58, +3.16 pct
Pfizer is negotiating a 2-3 percent break-up fee with Allergan, people familiar with the matter said. If Pfizer were to walk away from Allergan, it would have to pay $3 billion to $4.5 billion based on a $150 billion deal value, making it one of the highest ever break-up fees in dollar terms.
** INTUIT INC, $102.05, +4.75 pct
The tax-preparation software maker estimated full-year adjusted profit of $3.45-$3.50 per share, above the average analyst estimate of $3.43.
** ROSS STORES INC, $50, +8.23 pct
At least 3 brokerages raised their price targets by as much as $2 to as high as $61 after the off-price retailer increased its full-year 2015 profit forecast to $2.45-$2.48 per share from $2.40-$2.45
** WORKDAY INC, $82.85, -1.72 pct
The human resources software maker forecast current-quarter revenue below analysts' estimates and reported a bigger net loss for the third quarter.
** NATIONAL BANK OF GREECE, $0.2521, -32.05 pct
The troubled Greek lender priced its share offering at 0.02 euros per share, or at 0.30 euros per share reflecting 1-for-15 reverse share split. (Reporting by Nikhil Subba in Bengaluru; Editing by Kirti Pandey)